Search Results 41-50 of 13632 for Finasteride

1. Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer - Mayo Clinic

   Participants who are currently receiving Dutasteride (or have received it within the last 90 days) or Finasteride (or have received it within the last 30 ...

2. https://www.mayoclinic.org/patient_consumer_faq.xml

3. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

4. https://www.mayoclinic.org/arabic_patient_consumer_faq.xml

5. Radiation Therapy With Or Without Androgen-Deprivation Therapy In Treating Patients With Prostate Cancer - Mayo Clinic

   ... finasteride (90 days for dutasteride). Clinical stage T2b or T2c disease; Patients previously diagnosed with low-risk (Gleason score < 6, clinical stage < T2a ...

6. Hair loss - Doctors and departments - Mayo Clinic

   This common and sometimes stressful condition may result from heredity, medications or medical conditions. Treatment may reverse or slow hair loss.

7. Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women - Mayo Clinic

   The primary objective of this proposal is to conduct a study that assesses the safety, feasibility and efficacy of using PRP to treat this type of hair loss.

8. A Study to Evaluate Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer - Mayo Clinic

   Ten-day period following prostate biopsy; · Following initiation of hormonal therapy; · Within 30 days after discontinuation of finasteride; · Within 90 days after ...

9. Drugs and Supplements that Start with E - Mayo Clinic

   Finasteride and tadalafil (oral route) · Entecavir (oral route). EnteraGam. Also known as. Immune globulin bovine (oral route). Entercote. Also known as.

10. Chemotherapy and hair loss: What to expect during treatment - Mayo Clinic

    Your healthcare team can tell you whether your chemotherapy treatment is likely to cause hair loss. This allows you to plan for head coverings or treatments to ...